Pro-Dex Q1 FY2026: sales +24% to $18.5M, EPS $1.40 incl. $3.3M unrealized gains

PRO DEX INC

2026-Q1 EPS reported $1.40 revenue$18,530,000

Net sales rose 24% YoY to $18.5M driven by resumed next-generation handpiece production for largest customer.
Gross margin fell 6 points to 29% due to higher costs and tariffs not yet passed to customers.
Net income $4.7M ($1.40 diluted EPS) vs $2.5M ($0.75) a year ago; includes $3.3M unrealized investment gains.
Received $8.9M cash in October 2025 from Zimmer Biomet's acquisition of Monogram Technologies, valued at $4.04/share.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.